Holger Wagner
YOU?
Author Swipe
View article: Ligand recognition and activation of neuromedin U receptor 2
Ligand recognition and activation of neuromedin U receptor 2 Open
View article: Alzheimer’s disease-associated (hydroxy)methylomic changes in the brain and blood
Alzheimer’s disease-associated (hydroxy)methylomic changes in the brain and blood Open
View article: Reply: Biallelic <i>POLR3A</i> variants confirmed as a frequent cause of hereditary ataxia and spastic paraparesis
Reply: Biallelic <i>POLR3A</i> variants confirmed as a frequent cause of hereditary ataxia and spastic paraparesis Open
View article: MOESM1 of Alzheimer’s disease-associated (hydroxy)methylomic changes in the brain and blood
MOESM1 of Alzheimer’s disease-associated (hydroxy)methylomic changes in the brain and blood Open
Additional file 1. All Supplementary Tables (1–10), including descriptions.
View article: Exploring Genetic Associations of Alzheimer’s Disease Loci With Mild Cognitive Impairment Neurocognitive Endophenotypes
Exploring Genetic Associations of Alzheimer’s Disease Loci With Mild Cognitive Impairment Neurocognitive Endophenotypes Open
The role of genetic risk markers for Alzheimer's disease (AD) in mediating the neurocognitive endophenotypes (NEs) of subjects with mild cognitive impairment (MCI) has rarely been studied. The aim of the present study was to investigate th…
View article: Circulating metabolites and general cognitive ability and dementia: Evidence from 11 cohort studies
Circulating metabolites and general cognitive ability and dementia: Evidence from 11 cohort studies Open
INTRODUCTION: Identifying circulating metabolites that are associated with cognition and dementia may improve our understanding of the pathogenesis of dementia and provide crucial readouts for preventive and therapeutic interventions. METH…
View article: Circulating metabolites and general cognitive ability and dementia: Evidence from 11 cohort studies
Circulating metabolites and general cognitive ability and dementia: Evidence from 11 cohort studies Open
Introduction Identifying circulating metabolites that are associated with cognition and dementia may improve our understanding of the pathogenesis of dementia and provide crucial readouts for preventive and therapeutic interventions. Metho…
View article: Cerebrospinal fluid and blood biomarkers for neurodegenerative dementias: An update of the Consensus of the Task Force on Biological Markers in Psychiatry of the World Federation of Societies of Biological Psychiatry
Cerebrospinal fluid and blood biomarkers for neurodegenerative dementias: An update of the Consensus of the Task Force on Biological Markers in Psychiatry of the World Federation of Societies of Biological Psychiatry Open
In the 12 years since the publication of the first Consensus Paper of the WFSBP on biomarkers of neurodegenerative dementias, enormous advancement has taken place in the field, and the Task Force takes now the opportunity to extend and upd…
View article: Hypomorphic mutations in POLR3A are a frequent cause of sporadic and recessive spastic ataxia
Hypomorphic mutations in POLR3A are a frequent cause of sporadic and recessive spastic ataxia Open
Despite extensive efforts, half of patients with rare movement disorders such as hereditary spastic paraplegias and cerebellar ataxias remain genetically unexplained, implicating novel genes and unrecognized mutations in known genes. Non-c…
View article: Genome-wide significant risk factors for Alzheimer’s disease: role in progression to dementia due to Alzheimer's disease among subjects with mild cognitive impairment
Genome-wide significant risk factors for Alzheimer’s disease: role in progression to dementia due to Alzheimer's disease among subjects with mild cognitive impairment Open
Few data are available concerning the role of risk markers for Alzheimer's disease (AD) in progression to AD dementia among subjects with mild cognitive impairment (MCI). We therefore investigated the role of well-known AD-associated singl…
View article: PLD3 in non-familial Alzheimer's disease
PLD3 in non-familial Alzheimer's disease Open
Interest in the role of rare genetic variants in the aetiology of complex diseases such as Alzheimer's disease is increasing1,2. Recently, Cruchaga et al.3 provided evidence supporting the role of rare variants in the phospholipase D3 (PLD…